№5(6) 2023

DOI 10.37219/2528-8253-2023-5-9

Shydlovska TA, Bezeha,Volkova TV MI, Bezega BM

DISORDER OF SENSORY SYSTEMS – AUDITORY AND OLFACTORY ANALYSERS IN PATIENTS WHO HAVE HAD THE COVID-19

Shydlovska Tetiana A
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Head of the laboratory of voice and hearing
Doctor of Medical Sciences, Professor
E-mail: lorprof3@ukr.net  
Orchid ID: https://orcid.org/0000-0002-7894-359X

Bezega Mychailo I
Poltava State Medical University
Department of Otorhinolaryngology with Ophthalmology
Candidate of Medical Sciences
Email: bezega_lor@ukr.netlorbezega@gmail.com
ORCID ID: https://orcid.org/0000-0002-1250-1190

Volkova Tetyana V
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Laboratory for Occupational Voice and Hearing
Junior Researcher
E-mail: amtc@kndio.kiev.ua
Orchid ID: https://orcid.org/0000-0002-3830-1533

Bezeha Bohdan M
Communal enterprise «M.V. Sklifosovsky Poltava Regional Clinical Hospital Poltava Regional Council»
ENT department
Otolaryngologist
Email: bogdanbezegalor@gmail.com
ORCID ID: https://orcid.org/0000-0003-0517-9989

Abstract

Many disorders with various clinical manifestations are observed in COVID-19 coronavirus infection, including dam-age to the cardiovascular, central nervous systems and other organs and systems of the human body. The functions of sensory systems and higher nervous activity may also be affected by COVID-19. However, the issue is not sufficiently understood at the moment.

The purpose of the study is to assess the state of the sensory systems – auditory, taste and olfactory analysers in people with COVID-19 based on the analysis of complaints and anamnesis data, taking into account the severity of its course.

Materials and methods: We analysed survey data, anamnesis and complaints of 122 patients with COVID-19. All sub-jects were divided into two groups according to the clinical course of the disease: group 1 included patients with mild COVID-19 – 63 patients, and group 2 – 59 patients with moderate infection.

Results and discussion: In the more severe COVID-19, complaints of hearing, smell, voice, and vestibular function disorders are more frequent. At the same time, the manifestations of such sensory system disorders were more pronounced in patients in group 2. Patients in group 1 complained of hearing impairment in 41.3%, voice impairment in 26.9%, vestibular function in 33.3%, and general complaints from the central nervous system in 77.7%. In group 2, the following complaints were observed in a higher percentage of cases: hearing impairment 57.6%, voice impairment 33.9%, vestibular function 45.7%, and general CNS complaints 91.5%.

In general, 49.2% of the surveyed complained of hearing impairment in the form of decreased hearing sensitivity, changes in speech intelligibility, and tinnitus. After COVID-19 infection, even in mild form, 36.5% of patients often complained of hearing loss. The number of moderate cases was 42.4%. Patients also noted a deterioration in speech intelligibility (Group 1 – 14.3%, Group 2 – 16.9%) and tinnitus (Group 1 – 38.1%, Group 2 – 55.9%. In 36.9% of the examined patients, hearing impairment was present before COVID-19, and the disease led to the progression of HNP. In group 1, 33.3% of such cases were in group 2, and 40.7% in group 3.

The number of patients complaining of olfactory impairment in the first group was 65.1%, and in the second group – 69.4%. In all patients with olfactory disorders, such disorders occurred during the disease and, in most cases, disappeared after recovery, but in 4.8% of cases in group 1 and 16.9% in group 2, persistent olfactory disorders occurred that persisted for a long time, mainly in the form of anosmia and hyposmia.

When analysing the duration of some complaints, significant differences were found between the groups both during illness and long after recovery. The presence of long-term sensory systems and CNS disorders after COVID-19 is of the most significant interest. In group 2, persistent olfactory disorders in the form of anosmia (16.9%) and hyposomia (6.8%), hearing impairment (27.1%), subjective tinnitus (33,9%), ear congestion (16.9%), headache (45.7%), memory and attention disorders (44.1%), sleep disorders (45.7%), fatigue, general weakness (69.4%).

Thus, patients with COVID-19 often complain of impaired hearing, smell, taste, voice, vestibular function, and general CNS complaints. Moreover, there are often persistent disorders of sensory functions that persist for a long time after the dis-ease.

Conclusions:

  1. Patients with COVID-19 often have symptoms of sensory impairment – hearing, voice, smell, taste and vestibular function, as well as CNS conditions. These symptoms occur either during the disease or overtime after recovery and occur in both mild and moderate cases.
  2. The more severe COVID-19, the more frequent are complaints of sensory system disorders, and such manifestations are usually more pronounced and prolonged.
  3. In the mild form of COVID-19, the following symptoms of sensory system disorders were most commonly observed: decreased and distorted taste, decreased, distorted or exacerbated sense of smell, voice fatigue, dizziness, weakness, headaches, ear congestion, poor tolerance to loud sounds, which mostly resolve after recovery. The following sensory disorders were more common in moderate COVID-19 cases: prolonged hearing impairment (mainly prolonged secretory otitis media and sensorineural hearing loss), decreased or absent olfactory function, hoarseness, and vestibular disorders that persist long after recovery.
  4. Complaints of central nervous system disorders and hearing impairment occur even with mild COVID-19. Taste disorders are almost independent of the severity of the disease. Voice and smell disorders are more likely to be persistent after severe COVID-19.

Key words: COVID-19, auditory disorders, olfactory disorders.

References

  1. Almufarrij I, Uus K, Munro KJ. Does Coronavirus Affect the Audio-Vestibular System? a Rapid Systematic Review. Int J Audiol. 2020 Jul;59(7):487-491. doi: 10.1080/14992027.2020.1776406.
  2. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020 Jun 15;413:116832. doi: 10.1016/j.jns.2020.116832.
  3. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122.
  4. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26:368:m1091. doi: 10.1136/bmj.m1091.
  5. Ciorba A, Corazzi V, Skarzynski PH, Skarzynska MB, Bianchini C, Pelucchi S, Hatzopoulos. Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic! Int J Immunopathol Pharmacol. 2020 Jan-Dec; 34: 2058738420941754. doi: 10.1177/2058738420941754.
  6. Degen C, Lenarz T, Willenborg K. Acute profound sensorineural hearing loss after COVID-19 pneumonia. Mayo Clin Proc. 2020 Aug;95(8):1801-1803. doi: 10.1016/j.mayocp.2020.05.034.
  7. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep; 19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0.
  8. Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388.
  9. Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, Cetın F. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020 Aug;97:208-211. doi: 10.1016/j.ijid.2020.06.023.
  10. Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep. 2020 Oct 13;13(11):e238419. doi: 10.1136/bcr-2020-238419.
  11. Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol. 2020 Dec;59(12):889-890. doi: 10.1080/14992027.2020.1798519.
  12. Rhman SA, Wahid AA. COVID-19 and sudden sensorineural hearing loss: a case report. Otolaryngol Case Rep. 2020 Sep;16:100198. doi: 10.1016/j.xocr.2020.100198.
  13. Shydlovska TA, Bezega MI. [Indicators of subjective audiometry in the conventional frequency range in patients with COVID-19]. Otorhinolaryngology. 2022;5(5):23-28. doi: 10.37219/2528-8253-2022-5-23. [Article in Ukrainian].
  14. Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: a note. Am J Otolaryngol. 2020; 41(3):102473. doi: 10.1016/j.amjoto.2020.102473.
  15. Tavakoli A, Vahdat K, Keshavarz M. Novel coronavirus disease 2019 (COVID-19): an emerging infectious disease in the 21st Iran South Med J. 2020;22(6):432-450. doi: 10.29252/ismj.22.6.432.
  16. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 Jul:87:18-22. doi: 10.1016/j.bbi.2020.03.031.